Inducible nitric oxide synthase in pancreatic islets of the non-obese diabetic mouse: A light and confocal microscopical study of its ontogeny, co-localization and up-regulation following cytokine administration

Histochemical Journal

Volumn 29, Issue 1, 1997, Pages 53-64

  Reddy, S ^a   Kaill, S ^a   Poole, C A ^a   Ross, J ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; IMMUNOFLUORESCENCE; MACROPHAGE; MICROSCOPY; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

ANIMALS; CYTOKINES; DIABETES MELLITUS, TYPE 1; FEMALE; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; MICROSCOPY, CONFOCAL; NITRIC OXIDE SYNTHASE; UP-REGULATION;

ANIMALIA; RODENTIA;

EID: 0030905393     PISSN: 00182214     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026416918339     Document Type: Article

References (49)

1. CETKOVIC-CVRLJE, M. & EIZIRIK, D.L. (1994) TNF-α and IFN-γ potentiate the deleterious effects of IL-1β on mouse pancreatic islets mainly via generation of nitric oxide. Cytokine 6, 399-406.
2. CHESROWN, S.E., MONNIER, J., VISNER, G. & NICK, H.S. (1994) Regulation of inducible nitric oxide synthase mRNA levels by LPS, INF-γ, TGF-β and IL-10 in murine macrophage cell lines and rat peritoneal macrophages. Biochem. Biophys. Res. Commun. 200, 126-34.
3. CORBETT, J.A., MIKHAEL, A., SHIMIZU, J., FREDERICK, K., MISKO, T.P., MCDANIEL, M.L., KANAGAWA, O. & UNANUE, E.R. (1993a) Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process. Proc. Natl. Acad. Sci. USA 90, 8992-5.
4. CORBETT, J.A., SWEETLAND, M.A., WANG, J.L., LANCASTER, J.R. & MCDANIEL, M.L. (1993b) Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc. Natl. Acad. Sci. USA 90, 1731-5.
5. CORBETT, J.A. & MCDANIEL, M.L. (1995) Intraislet release of interleukin 1 inhibits β cell function by inducing β cell expression of inducible nitric oxide synthase. J. Exp. Med. 181, 559-68.
6. CORBETT, J.A., WANG, J.L., SWEETLAND, M.A., LANCASTER, J.R. & MCDANIEL, M.L. (1992) Interleukin 1β induces the formation of nitric oxide by β-cells purified from rodent islets of Langerhans. Evidence for the β-cell as a source and site of action of nitric oxide. J. Clin. Invest. 90, 2384-91.
7. DUNGER, A., CUNNINGHAM, J.M., DELANEY, C.A., LOWE, J.E., GREEN, M.H.L., BONE, A.J. & GREEN, I.C. (1996) Tumour necrosis factor-α and interferon-γ inhibit insulin secretion and cause DNA damage in unweaned-rat islets: extent of nitric oxide involvement. Diabetes 45, 183-9.
8. EIZIRIK, D.L., BJORKLUND, A. & WELSH, N. (1993) Interleukin-1-induced expression of nitric oxide synthase in insulin-producing cells is preceded by c-fos induction and depends on gene transcription and protein synthesis. FEBS Lett. 317, 62-6.
9. HELD, W., MACDONALD, H.R., WEISSMAN, I.L., HESS, M.W. & MUELLER, C. (1990) Genes encoding tumour necrosis factor α and granzyme A are expressed during development of autoimmune diabetes. Proc. Natl. Acad. Sci. USA 87, 2239-43.
10. HIBBS, J.B., WESTENFELDER, C., TAINTOR, R., VAVRIN, Z., KABLITZ, C., BARANOWSKI, R.L., WARD, J.H., MENLOVE, R.L., MCMURRY, M.P., KUSHNER, J.P. & SAMLOWSKI, W.E. (1992) Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J. Clin. Invest. 89, 867-77.
11. HOLSTAD, M. & SANDLER, S. (1993) Aminoguanidine, an inhibitor of nitric oxide formation, fails to protect against insulitis and hyperglycaemia induced by multiple low dose streptozotocin injections in mice. Autoimmunity 15, 311-14.
12. HUKKANEN, M., HUGHES, F.J., BUTTERY, L.D.K., GROSS, S.S., EVANS, T.J., SEDDON, S., RIVEROS-MORENO, V., MACINTYRE, I. & POLAK, J.M. (1995) Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity. Endocrinology 136, 5445-53.
13. JAFARIAN-TEHRANI, M., AMRANI, A., HOMO-DELARCHE, F., MARQUETTE, C., DARDENNE, M. & HAOUR, F. (1995) Localization and characterization of interleukin-1 receptors in the islets of Langerhans from control and nonobese diabetic mice. Endocrinology 136, 609-13.
14. JANSEN, A., COOK, T., TAYLOR, G.M., LARGEN, P., RIVEROS-MORENO, V., MONCADA, S. & CATTELL, V. (1994) Induction of nitric oxide synthase in rat immune complex glomerulonephritis. Kidney Int. 45, 1215-19.
15. JIANG, Z. & WODA, B.A. (1991) Cytokine gene expression in the islets of the diabetic biobreeding/Worcester rat. J. Immunol. 146, 2990-4.
16. KALLMANN, B., BURKART, V., KKONCKE, K-D., KOLBBACHOVEN, v. & KOLB, H. (1992) Toxicity of chemically generated nitric oxide towards pancreatic islet cells can be prevented by nicotinamide. Life Sci. 51, 671-8.
17. KANETO, H., FUJII, J., SEO, H.G., SUZUKI, K., MATSUOKA, T-A., NAKAMURA, M., TATSUMI, H., YAMASAKI, Y., KAMADA, T. & TANIGUCHI, N. (1995) Apoptic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes 44, 733-8.
18. KARLSEN, A.E., ANDERSEN, H.U., VISSING, H., LARSEN, P.M., FEY, S.J., CUARTERO, B.G., MADSEN, O.D., PETERSEN, J.S., MORTENSEN, S.B., MANDRUP-POULSEN, T., BOEL, E. & NERUP, J. (1995) Cloning and expression of cytokine-inducible nitric oxide synthase cDNA from rat islets of Langerhans. Diabetes 44, 753-8.
19. KASAI, K., HATTORI, Y., NAKANISHI, N., MANAKA, K., BANBA, N., MOTOHASHI, S. & SHIMODA, S.I (1995) Regulation of inducible nitric oxide production by cytokines in human thyrocytes in culture. Endocrinology 136, 4261-70.
20. KLEEMANN, R., ROTHE, H., KOLB-BACHOFEN, V., XIE, Q-W., NATHAN, C., MARTIN, S. & KOLB, H. (1993) Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats. FEBS Lett. 328, 9-12.
21. KOLB, H., KIESEL, V., KRONCKE, K-D. & KOLB-BACHOVEN, V. (1991) Suppression of low dose streptozotocin induced diabetes in mice by administration of a nitric oxide synthase inhibitor. Life Sci. 49, 213-17.
22. KRONCKE, K., STEINER, L., FEHSEL, K. & KOLB-BACHOFEN, v. (1995) Cytokine-activated capillary-forming islet endothelial cells lyse beta-cells via nitric oxide generation. Autoimmunity 21, 42.
23. (1)-nitro-L-arginine methyl ester reduces the incidence of IDDM in BB/E rats. Diabetes 44, 365-8.
24. LUKIC, M.L., STOSIC-GRUJUCIC, S., OSTOJIC, N., CHAN, W.L. & LIEW, F.Y. (1991) Inhibition of nitric oxide generation affects the induction of diabetes by streptozotocin in mice. Biochem. Biophys. Res. Commun. 178, 913-20.
25. MACMICKING, J.D., NATHAN, C., HOM, G., CHARTRAIN, N., FLETCHER, D.S., TRUMBAUER, M., STEVENS, K., XIE, Q-W., SOKOL, K., HUTCHINSON, N., CHEN, H. & MUDGETT, J.S. (1995) Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81, 641-50.
26. MANDRUP-POULSEN, T., HELQVIST, S., MOLVIG, J., WOGENSEN, L.D & NERUP, J. (1989) Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin-dependent diabetes mellitus. Autoimmunity 4, 191-218.
27. MANDRUP-POULSEN, T., HELQVIST, S., WOGENSEN, L.D., MOLVIG, J., POCIOT, F., JOHANNESEN, J. & NERUP, J. (1990) Cytokines and free radicals as effector molecules in the destruction of pancreatic beta cells. In Human Diabetes - Genetic, Environmental and Autoimmune Etiology. (edited by BAEKKESKOV, S. & HANSEN, B.) pp. 169-93. Heidelberg: Springer-Verlag.
28. MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-42.
29. PIPELEERS, D.G. (1992) Heterogeneity in pancreatic β-cell population. Diabetes 41, 777-81.
30. RABINOVITCH, A., SUAREZ-PINZON, W.L., SORENSEN, O. & BLEACKLEY, R.C. (1996) Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS expressing cells and relationships to cytokines expressed in the islets. Endocrinology 137, 2093-9.
31. REDDY, S., BIBBY, N.J. & ELLIOTT, R.B. (1988) Ontogeny of islet cell antibodies, insulin autoantibodies and insulitis in the non-obese diabetic mouse. Diabetologia 31, 322-8.
32. REDDY S., LIU, W. & ELLIOTT, R.B. (1993) Distribution of pancreatic macrophages preceding and during insulitis in young NOD mice. Pancreas 8, 602-8.
33. REDDY, S., SALARI-LAK, N. & SANDLER, S. (1995a) Long-term effects of nicotinamide-induced inhibition of poly(adenosine diphosphate-ribose) polymerase activity in rat pancreatic islets exposed to interleukin-1β. Endocrinology 136, 1907-12.
34. REDDY, S., WU, D., SWINNEY, C. & ELLIOTT, R.B. (1995b) Immunohistochemical analyses of pancreatic macrophages and CD4 and CD8 T cell subsets prior to and following diabetes in the NOD mouse. Pancreas 11, 16-25.
35. REDDY, S., WU, D. & POOLE, C.A. (1996) Glutamic acid decarboxylase 65 and 67 isoforms in fetal, neonatal and adult porcine islets: predominant beta cell co-localization by light and confocal microscopy. J. Autoimmun. 9, 21-7.
36. ROTHE, H., FAUST, A., SCHADE, U., KLEEMANN, R., BOSSE, G., HIBINO, T., MARTIN, S. & KOLB, H. (1994) Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4. Diabetologia 37, 1154-8.
37. SANDLER, S., ANDERSSON, A. & HELLERSTROM, C. (1987) Inhibitory effects of interleukin-1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 121, 1424-31.
38. SANDLER, S., EIZIRIK, D.L., SVENSSON, C., STRANDELL, E., WELSH, M. & WELSH, N. (1991) Biochemical and molecular actions of interleukin-1 on pancreatic β-cells. Autoimmunity 10, 241-53.
39. SIGNORE, A., POZZILLI, P., GALE, E.A.M., ANDREANI, D. & BEVERLEY, P.C.L. (1989) The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice. Diabetologia 32, 282-9.
40. SOUTHERN, C., SCHULSTER, D. & GREEN, I.C. (1990) Inhibition of insulin secretion by interleukin-1β and tumour necrosis factor-α by an L-arginine-dependent nitric oxide generating mechanism. FEBS Lett. 276, 42-4.
41. STERNESJO, J., BENDTZEN, K. & SANDLER, S. (1995) Effects of prolonged exposure in vitro to interferon-γ and tumour necrosis factor-α on nitric oxide and insulin production of rat pancreatic islets. Autoimmunity 20, 185-90.
42. SUAREZ-PINZON, W.L., STRYNADKA, K., SCHULZ, R. & RABINOVITCH, A. (1994) Mechanisms of cytokine-induced destruction of rat insulinoma cells: the role of nitric oxide. Endocrinology 134, 1006-10.
43. WEIR, G.C. & BONNER-WEIR, S. (1990) Islets of Langerhans: the puzzle of intraislet interactions and their relevance to diabetes. J. Clin. Invest. 85, 983-7.
44. WELSH, N., EIZIRIK, D.L., BENDTZEN, K. & SANDLER, S. (1991) Interleukin-1β induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme, aconitase. Endocrinology 129, 3167-73.
45. WELSH, N., EIZIRIK, D.L. & SANDLER, S. (1994) Nitric oxide and pancreatic β-cell destruction in insulin dependent diabetes mellitus: don't take NO for an answer. Autoimmunity 18, 285-90.
46. WELSH, M., WELSH, N., BENDTZEN, K., MARES, J., STRANDELL, E., OBERG, C. & SANDLER, S. (1995) Comparison of mRNA contents of interleukin-1β and nitric oxide synthase in pancreatic islets isolated from female and male nonobese diabetic mice. Diabetologia 38, 153-60.
47. WHITTLE, B.J.R. (1995) Nitric oxide in physiology and pathology. Histochem. J. 27, 727-37.
48. G-monomethyl-L-arginine on the onset of diabetes in the spontaneously diabetic BB rat. Diabetes 44, 360-4.
49. XIE, Q-W., CHO, H.J., CALAYCAY, J., MUMFORD, R.A., SWIDEREK, K.M., LEE, T.D., DING, A., TROSO, T. & NATHAN, C. (1992) Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256, 225-8.